Meta-analyses and megatrials: Neither is the infallible, universal standard

Evidence-Based Mental Health

Volumn 7, Issue 2, 2004, Pages 34-35

  Furukawa, Toshi ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EVIDENCE BASED MEDICINE; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL;

EVIDENCE-BASED MEDICINE; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS;

EID: 2342494361     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebmh.7.2.34     Document Type: Short Survey

References (13)

1. Jadad AR, Cook DJ, Browman GP. A guide to interpreting discordant systematic reviews. Can Med Assoc J 1997;156:1411-16. (Pubitemid 27237111)
2. LeLorier J, Gregoire G, Benhaddad A, et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997;337:536-42. (Pubitemid 27352021)
3. Ioannidis JPA, Cappelleri JC, Lau J. Issues in comparisons between meta-analyses and large trials. JAMA 1998;279:1089-93. (Pubitemid 28177817)
4. Furukawa TA, Streiner DL, Hori S. Discrepancies among megatrials. J Clin Epidemiol 2000;53:1193-9. (Pubitemid 32007834)
5. Glasziou P, Vandenbroucke J, Chalmers I. Assessing the quality of research. BMJ 2004;328:39-41. (Pubitemid 38067746)
6. Peuskens J. Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group. Br J Psychiatry 1995;166:712-26; discussion 727-33.
7. Hunter RH, Joy CB, Kennedy E, et al. Risperidone versus typical antipsychotic medication for schizophrenia. Cochrane Database Syst Rev 2003;(2):CD000440.
8. Burgess S, Geddes J, Hawton K, et al. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev 2001;(3):CD003013.
9. Bowden CL, Calabrese JR, McElroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000;57:481-9. (Pubitemid 30257262)
10. Bowden CL, Calabrese JR, Sachs G, et al. Lamictal 606 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392-400.
11. Jonas JM, Cohon MS. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature. J Clin Psychiatry 1993;54(Suppl):25-45; discussion 46-8.
12. Marks IM, Swinson RP, Basoglu M, et al. Alprazolam and exposure alone and combined in panic disorder with agoraphobia: a controlled study in London and Toronto. Br J Psychiatry 1993;162:776-87. (Pubitemid 23168359)
13. Popper K. The Logic of Scientific Discovery. 15th edn. London: Routledge, 2002.